A number of pathways are involved in the regulation of glucose in cancer cells, posing hurdles in the pathway of PI3K signaling or the selective blockage of glucose transporter type1 (GLUT1), thereby resulting in low glucose uptake [48,49]. The gene discussed is SLC2A1; the disease is cancer.